Determination of the rate of reduction in platelet counts in recipients of hematopoietic stem and progenitor cell transplant: Clinical implications for platelet transfusion therapy

Transfusion

Volumn 37, Issue 11-12, 1997, Pages 1163-1168

  Del Rosario, M L U ^a,b   Kao, K J ^a,b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; STEM CELL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0031461310     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37111298088046.x     Document Type: Article

References (13)

1. Schiffer CA, Slichter SJ. Sounding board: platelet transfusions from single donors. N Engl J Med 1982;307:245-8.
2. Menitove JE, Aster RH. Transfusion of platelets and plasma products. Clin Haematol 1983;12:239-66.
3. Slichter SJ. Transfusion and bone marrow transplantation. Transfusion Med Rev 1988;2:1-17.
4. DeCoteau J, Haddad S, Blanchette V, Poon A. Refractoriness to platelet transfusions in children with acute leukemia. J Pediatr Hematol Oncol 1995;17:306-10.
5. Hogge DE, McConnell M, Jacobson C, et al. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients. Transfusion 1995;35:645-52.
6. TRAP Trial Study Group. Leukocyte-reduction and UV-B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med (accepted).
7. Daly PA, Schiffer CA, Aisner J, Wiernik PH. Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA 1980;243:435-8.
8. Hogge DE, Dutcher JP, Aisner J, Schiffer CA. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 1983;14:363-9.
9. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;66:1105-9.
10. Shulman NR, Jordan JV Jr, Falchuk S. A normal fixed-loss component of platelet utilization accounting for short survival of transfused platelets. Ann NY Acad Sci 1985;459:367-74.
11. Murphy S, Kahn RA, Holme S, et al. Improved storage of platelets for transfusion in a new container. Blood 1982;60:194-200.
12. Rock G, Sherring VA, Tittley P. Five-day storage of platelet concentrates. Transfusion 1984;24:147-52.
13. Cottler-Fox M, Lynch M, Pickle LW, et al. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels. Bone Marrow Transplant 1991;8:27-33.